[1] | Abanmi A, Alharthi F, Alagla R, Khan HA, Tariq M. Serum levels of proinflammatory cytokines in psoriasis patients from Saudi Arabia. Int J Dermatol; 44(1):82-83, 2005. |
[2] | Kunkel SL, Chensue SW, Strieter RM, Lynch JP, Remick DG. Cellular and molecular aspects of granulomatous inflammation. Am J Respir Cell Mol Biol. 1(6):439-47, 1989. |
[3] | Firestein GS, Budd RC, Harris ED, McInnes LB, Ruddy S, Sergent JS. Kkelley's textbook of rheumatology. 8th ed. Philadelphia: Saunders; 2008. |
[4] | Uyemura K, Yamamur M, Fivenson DF, Modlin RL, Nickoloff BJ. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol21;101:701-705,1993. |
[5] | Asadullah K, Volk HD, Sterry W. Novel immunotherapies for psoriasis. Trends in Immunology.23:47-53, 2002. |
[6] | Caproni M, Antiga E, Melani L, Volpi W, Bianco ED, Fabbri P. Serum levels of IL-17 and IL-22 are reduced by Etanercept, but not by Acitretin, in patients with psoriasis: a randomized-controlled trial. J Clin Immunol 29:210-214, 2008. |
[7] | El Hadidi H, Grace BDM ,Gheita T, Shaker O. Involvement of IL-23 in psoriasis and psoriatic arthritis patients; possible role in pathogenesis. J Egypt worn Dermatol Soc; 5(2):70-75, 2008. |
[8] | Nakajima H, Nakajima K, Tarutani M, Morishige R, Sano S. Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients. Arch Dermatol Res August; 303(6): 451–455, 2011. |
[9] | Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, Gianetti A, Girolomoni G. Prevalence of metabolic syndrome in patients with psoriasis. Br J Dermatol 157:68-73, 2007. |
[10] | Takahashi H, Tsuji H, Takahashi I, Hashimoto Y, Yamamoto AI, Iizuka H. Plasma adiponectin and leptin levels in Japanese patients with psoriasis. Br J Dermatol; 159(5):1207-1208, 2008. |
[11] | Wilson D, Varigos G, Ackland ML. Apoptosis may underlie the pathology of zinc-deficient skin. Immunol Cell Biol 84:28-37, 2006. |
[12] | Bao B, Prasad AS, Beck FWJ, Godmere M. Zinc modulates mRNA levels of cytokines. Am J Physiol Endocrinol Metab 17; 285:1095-1102, 2003. |
[13] | Rink L, Kirchner H. Zinc-altered immune function and cytokine production. J Nutr 130(5):1407-1411, 2000. |
[14] | Tam M, Gómez S, González M, Marcos A. Possible roles of magnesium on the immune system. Eur J Clin Nutr; 57:1193-1197, 2003. |
[15] | Muñoz C, López M, Olivares M, Pizarro F, Arredondo M, Araya M. Differential response of interleukin-2 production to chronic copper supplementation in healthy humans. Eur Cytokine Netw 16(4):261-265, 2005. |
[16] | Nast A, Boehncke WH, Mrowietz U, Ockenfels HM, Philipp S. Guidelines on the treatment of psoriasis vulgaris, Update JDDG 9(S2):S1-S95,2011. |
[17] | Dang PM, Elbim C, Marie JC, Chiandotto M, Pocidalo MA, El-Benna J. Anti-inflammatory effect of interleukin -10 on human neutrophil respiratory burst involves inhibition of GM-CSF-induced p47PHOX phosphorylation through a decrease in ERK1/2 activity. FASEB J 20:E698-E709, 2006. |
[18] | Borska L, Andrys C, Krejsek J, Hamakova K, Kremlacek J, Ettler K, Fiala Z. Serum levels of the proinflammatory cytokine interleukin-12 and the anti-inflammatory cytokine-10 in patients with psoriasis treated by the Goeckerman regimen. Int J Dermatol 47:800-805, 2008. |
[19] | Elkhayam O, Yaron I, Shirazi I, Yaron M, Caspi D. Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis. Rheumatol Internat 19:101-105, 2000. |
[20] | Deeva I., Mariani S., De Luca C., Pacifico V., Leoni L., Raskovic D., Kharaeva Z., Korkina L., Pastore S. Wide-spectrum profile of inflammatory mediators in the plasma and scales of patients with psoriatic disease. Cytokine. 49(2):163-70, 2010. |
[21] | Jacob SE, Nassiri M, Kerdel FA, Vincek V. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity. Mediat Inflamm. 12(5):309–13, 2003. |
[22] | Antiga E, Del Bianco E, Difonzo E, Fabrri P, Caproni M. Serum levels of the regulatory cytokines transforming growth factor-β and interleukin-10 are reduced in patients with discoid lupus erythematouses. Lupus 20:556-560, 2010. |
[23] | Jadali Z, Izad M, Eslami MB, Mansouri P, Safari R, Bayatian P, Mirshafiey A and Salehi Nodeh AR. Th1/Th2 cytokines in psoriasis. Iranian J Public Health 36:87-91, 2007. |
[24] | Verghese B, Bhatnagar S, Tanwar R, Bhattacharjee J. Serum cytokine profile in psoriasis: a case control study in a tertiary care hospital from northern india. Ind J Clin Biochem 26:373-377, 2011. |
[25] | Takahashi H, Tsuji H, Hashimato Y, Yamamoto AI, Iizuka H. Serum cytokines and growth factor levels in Japanese patients with psoriasis. Clin Exp Dermatol 35:645-649, 2010. |
[26] | Mitzutani H, Ohmoto Y, Mizutani T, Murata M, Shimizu M. Role of increased production of monocytes TNF-α, IL-1β and IL-6 in psoriasis: relation to focal infection, disease activity and responses to treatment. J Dermatol Sci 14:145-153, 1997. |
[27] | Germann, T., and E. Rude-E. Interleukin-12. Int. Arch. Allergy Immunol. 108:103–112, 1995. |
[28] | Jung SH, Park HS, Kim KS, Choi WH, Ahn CW, Kim BT, Kim SM, Lee SY, Ahn SM, Kim YK, Kim HJ, Kim DJ, Lee KW. Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss. J Nutr Biochem 19:371–375,2008. |
[29] | Toichi E, Torres G, McCormick TS, Chang T, Mascelli MA, Kauffman CL, Aria N, Gottlieb AB, Everitt DE, Frederick B, Pendley CE, Cooper KD. An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis. J Immunol 177:4917-26, 2006. |
[30] | Trepicchio, W. L., M. Ozawa, I. B. Walters, T. Kikuchi, P. Gilleaudeau, J. L. Bliss, U. Schwertschlag, A. J. Dorner, and J. G. Krueger. Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions. J. Clin. Invest. 104: 1527–1537, 1999. |
[31] | Olaniran, A. K., B. S. Baker, D. G. Paige, J. J. Garioch, A. V. Powles, and L. Fry. Cytokine expression in psoriatic skin lesions during PUVA therapy. Arch Dermatol. Res. 288: 421–425, 1996. |
[32] | Asadullah, K., W. Sterry, K. Stephanek, D. Jasulaitis, M. Leupold, H. Audring, H. D. Volk, and W. D. Docke. IL-10 is a key cytokine in psoriasis: proof of principle by IL-10 therapy: a new therapeutic approach. J. Clin. Invest. 101:783–794, 1998. |
[33] | Yawalkar N, Karlen S, Hunger R, Brand CU, Braathen LR. Expression of interleukin-12 is increased in psoriatic skin. J Invest Dermatol 111:1053-1057, 1998. |
[34] | Coimbra S, Oliveira H, Reis F, Belo L, Rocha S, Quaintanilha A, Figueiredo A, Teixeira F, ... Teixeira F, Castro E, Rocha-Pereira P, Santos-Silva A. Interleukin (IL)-22,IL-17, IL-23, IL-8, vascular endothelial growth factor and tumor necrosis factor-α levels in patients with psoriasis before, during and after psoralen ultraviolet A and narrowband ultraviolet B therapy. Br J Dermatol 163:1282-1290, 2010. |
[35] | Sumarac-Dumanovic M, Stevanovic D, Ljubic A, Jorga J, Simic M, Stamenkovic-Pejkovic D, Starcevic, V.; Trajkovic, V.; Micic, D. Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes 33:151-156, 2009. |
[36] | Sumarac-Dumanovic M, Micic D, Simic M, Stamenkovic-Pejkovic D, Stevanovic D, Jorga J, Cvijovic G, Zoric S, Trajkovic V. Relationship between obesity, IL-17 and IL-23 and insulin resistance. Endocr Abst 16:568, 2008. |
[37] | Naldi L, Chatenoud L, Linder D, Belloni Fortina A, Peserico A, Virgili AR, Bruni PL, Ingordo V, Lo Scocco G, Solaroli C, Schena D, Barba A, Di Landro A, Pezzarossa E, Arcangeli F, Gianni C, Betti R, Carli P, Farris A, Barabino GF, La Vecchia C. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case–control study. J Invest Dermatol 125:61–67, 2005. |
[38] | Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 32:982–986, 1995. |
[39] | Raychaudhuri SP, Gross J. Psoriasis risk factors: role of lifestyle practices. Cutis 66:348–352, 2000. |
[40] | Marino MG, Carboni I, De Felice C, Maurici M, Maccari F, Franco E. Risk factors for psoriasis: a retrospective study on 501 outpatient's clinical records. Ann Ig 16:753–758, 2004. |
[41] | Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand GM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55:829–835, 2006. |
[42] | Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 298:321–328, 2006. |
[43] | Herron MD, Hinckley M, Hoffman MS, Papenfuss J, Hansen CB, Callis KP, Krueger GG. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 141:1527–1534, 2005. |
[44] | Wok K. Witte E, Wallace E, Docke WD, Kunz S, Asadullah K, Volk HD, Sterry W, and Sabat R: IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36:1309-1323,2006. |
[45] | Corbita S, Angioni R, Cattaneo A, Peccoz PB, Spada A. Effects of retinoid therapy on insulin sensitivity, lipid profile and circulating adipokines. Eur J Endocrinol 154:83-86, 2006. |
[46] | Shibatta S, Saek H, Tada Y, Karakawa M, Komine M, Tamaki K. Serum high molecular weight adiponectin levels are decreased in psoriasis patients. J Dermatol Sci 55:62-63, 2009. |
[47] | Kaur S, Zilmer K, Kairane C, Kals M, Zilmer M. Clear differences in adiponectin level and glutathione redox status revealed in obese and normal weight patients with psoriasis. Br J Dermatol 159:1364-1367, 2008. |
[48] | Matsuzaka Y. The metabolic syndrome and adipokines. FEBS Lett 580:2917-2921, 2006. |
[49] | Hulthe J, Hulten LM, Fagerberg B. Low adipocyte-derived plasma protein adiponectin concentrations are associated with metabolic syndrome and small dense low density lipoprotein particles: atherosclerosis and insulin resistance study. Metabolism 52:1612-1614, 2003. |
[50] | Campfield LA, Smith FJ, GuisezY, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269:546-549, 1995. |
[51] | Boehncke S, Thaci D, Beshmann H, Ludwig RJ, Ackermann H, Badenhoop K, Boehncke WH. Psoriasis patients show signs of insulin resistance. Br J Dermatol. 157:1249-1251,2007. |
[52] | Komai N, Morita Y, Sakuta T, Kuwabara A, Kashihara N. Anti-tumor necrosis factor therapy increase adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis. Mod Rheumatol 17:385-390, 2007. |
[53] | Ouchi N, Walsh K. Adiponectin as anti-inflammatory factor. Clin Chim Acta 380:24-30, 2007. |
[54] | Sommer DM, Jenisch S, Suchan M, Christopher E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 298:321-328, 2006. |
[55] | Silswal N, Singh AK, Aruna B, Mukhoppadhayay S, Gosh S, Ehtesham NZ. Human resisten stimulates the pro-inflammatory cytokines TNF-α and IL-12 in macrophages by NF-κ B- dependent pathway. Biochem Biophys Res Commun 334:1092-1101, 2005. |
[56] | Gerdes S, Rostami-Yanzdi M, Mrowietz U. Adipokines and psoriasis. Exp Dermatol 20:81-87, 2011. |
[57] | Takahashi H, Tsuji H, Hashimoto Y, Ishida-Yamamoto A, Iizuka H. Serum cytokine and growth factor levels in Japanese patients with psoriasis. Clin Exp Dermatol 35:645-649, 2009. |
[58] | Bao B, Prasad AS, Beck FWJ, Godmere M. Zinc modulates mRNA levels of cytokines. Am J Physiol Endocrinol Metab 285:1095-1102, 2003. |
[59] | Molokhia MM, Portnoy B. Neutron activation analysis of trace elements in skin.V. copper and zinc in psoriasis. Br J Dermatol 83:376-381, 1970. |
[60] | Hinks LJ, Young S, Clayton B. Trace element status in eczema and psoriasis. Clin Exp Dermatol 12:93-97, 1987. |
[61] | Ozturk G, Erbas D, Gelier E, Gulekon A, Imir T. Natural killer cell activity, serum immunoglobulins, complement proteins, and zinc levels in patients with psoriasis vulgaris. Immunol Invest 30:181-190, 2001. |
[62] | Kreft B, Wohlrab J, Fischer M, Uhlig H, Skolziger R, Marsch WC. Analysis of serum zinc level in patients with atopic dermatitis, Psoriasis vulgaris and in probands with healthy skin. Hautazt 51:931-934, 2000. |
[63] | Greaves M, Boyde TRC. Plasma zinc concentrations in patients with psoriasis, other dermatoses, and venous legulceration. Lancet 290:1019-1020, 1967. |
[64] | Nigam PK. Serum zinc and copper levels and Cu: Zn ratio in psoriasis. Indian J Dermatol Venereol Leprol 71:205-205, 2005. |
[65] | Madadi A, Sethi N, Bhandari S. A study of serum zinc, copper, magnesium, proteins and enzyme superoxide dismutase in psoriasis. Indian J Dermatol Venereol Leprol 60:319-322, 1994. |
[66] | Arora PN, Dhillon KS, Rajan SR, Sayal SK, Das AL. Serum zinc levels in cutaneous disorders. MJAFI 58: 304-306, 2002. |
[67] | Basavaraj KH, Darshan MS, Shanmugavelu P, Rashmi R, Mahatre AY, Dhanabal SP, Rao KS... Study on the levels of trace elements in mild and severe psoriasis. Clinica Chimica Acta 405:66-70, 2009. |
[68] | Butnaru C, Pascu M, Mircea C, Agoroaei L, Solovastru L, Vata D, Butnaru E, Petrescu Z. Serum zinc and copper levels in some dermatological diseases. Rev Med Chir Soc Med Nat LasiLasi 112:253-257, 2008. |
[69] | Bhatnagar M, Bapna A, Khare AK. Serum proteins, trace metals and phosphatases in psoriasis. Indian J Dermatol Vevereol Leprol 60:18-21, 1994. |
[70] | Saxena N, Sharma RP, Singh VS. Study of serum zinc levels in leprosy. Int J Lep 60:556-61, 1988. |
[71] | McMillan EM, Rowe D. Plasma zinc in psoriasis in relation to surface area involvement. Br J Derm 100; 1301-1305, 1983. |
[72] | Rashmi R, Yuti AM, Basavaraj KH. Relevance of copper and ceruloplasmin in Zackheim HS, Wolf P. Serum copper in psoriasis and other dermatoses. J Invest Dermatol 58:28-32, 1972. |
[73] | Vink R, Donkin JJ, Cruz MI, Nimmo AJ, Cernak I. A substance P antagonist increases brain injury in rats. Am Coll Nut 23:538S-540S, 2004. |
[74] | Goodman WA, Levine AD, Massari JV, Sugiyama H, McCormick TS, Cooper KD. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J Immunol 183:3170-3176, 2009. |
[75] | Victor FC, Gottlieb AB. TNF-alpha and apoptosis: implications for the pathogenesis and treatment of psoriasis. J Drugs Dermatol 1:264-275, 2002. |
[76] | Pories WJ, Mansur EG. In: Prasad AS, D'Oberleas, Editors. 'Trace elements in human health and diseases. New York Acad Press, P115, 1976. |
[77] | Day C, McCollum EV. Effect of acute dilatory zinc deficiency in rat. Proc Exp Bio Med 45:282-287, 1940. |
[78] | Portnoy K, Molokhia M. Zinc and copper in psoriasis. Br J Dermatol 86:205-209, 1972. |
[79] | Prasad AS: Discovery of human zinc deficiency and studies in an experimental human model. Am J Clin Nutr 53(2): 403-412, 1991. |
[80] | Marreiro Ddo N, Fisberg M and Cozzolion SM: Zinc nutritional status and its relationships with hyperinsulinemia in obese children and adolescents. Biol Trace Elem Res 100(2): 137-149, 2004. |
[81] | Canatan H, Bakan I, Akbulut M, Halifeoglu I, Cikim G, Baydas G and Kilic N: Relationship among levels of leptin and zinc, copper, and zinc/copper ratio in plasma of patients with essential hypertension and healthy normotensive subjects. Biol Trace Elem Res 100(2): 117-123, 2004. |
[82] | Chen MD, Song YM and Lin PY: Zinc may be a mediator of leptin production in humans. Life Sci 66(22): 2143-2149, 2000. |
[83] | Tungtrongchitr R, Pongpaew P, Phonrat B, Tungtrongchitr A, Viroonudomphol D, Vudhivai N and Schelp FP: Serum copper, zinc, ceruloplasmin and superoxide dismutase in Thai overweight and obese. J Med Assoc Thai 86(6): 543-551, 2003. |
[84] | Tallman DL and Taylor CG: Effects of dietary fat and zinc on adiposity, serum leptin and adipose fatty acid composition in C57BL/6J mice. J Nutr Biochem 14(1): 17-23, 2003. |
[85] | Di Toro, Marotta A, Todisco N, Ponticiello E, Collini R, Di Lascio R and Perrone L: Unchanged iron and copper and increased zinc in the blood of obese children after two hypocaloric diets. Biol Trace Elem Res 57(2): 97-104, 1997. |
[86] | Yuko S, Yasuo K, Sakamoto S. Increased Plasma Levels of Zinc in Obese Adult Females on a Weight-loss Program Based on a Hypocaloric Balanced Diet. In Vivo 19: 1035-1038, 2005. |